Annual report pursuant to Section 13 and 15(d)

Consolidated Statement of Changes in Temporary Equity and StockHolders' Deficiency (Parenthetical)

v3.22.1
Consolidated Statement of Changes in Temporary Equity and StockHolders' Deficiency (Parenthetical)
12 Months Ended
Dec. 31, 2021
USD ($)
Subsidiary, Sale of Stock [Line Items]  
Common stock issued for cash, net of offering costs $ 4,177,400
Cash payments for offering costs 319,684
Underwriter [Member]  
Subsidiary, Sale of Stock [Line Items]  
Gross proceeds from public offering 8,002,004
Professional fees 715,000
Common stock issued for cash, net of offering costs 364,979
Cash payments for offering costs 319,684
Private Placement [Member]  
Subsidiary, Sale of Stock [Line Items]  
Gross proceeds from public offering 5,135,210
Common stock issued for cash, net of offering costs 500,000
Commission paid $ 457,810